Nixon Peabody
Bank of America
You are here:  Home  >  Biotech  >  Current Article

Sientra misses earnings estimates as net loss grows

By   /   Monday, May 11th, 2020  /   No Comments

    Print       Email
Sales declined slightly in the first quarter for Goleta breast implant maker Sientra, and net loss rose 8 percent to $28.6 million or 57 cents per share. Revenues of $16.9 million missed analyst estimates, sending shares down 5.6 percent to $2.28 in after-hours trading.  The impacts of COVID-19 were strongest in the final weeks of…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

Leave a Reply

Your email address will not be published. Required fields are marked *

You might also like...

Hair: Predictions for the future of commercial real estate

Read More →